Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer

Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer

(2010) Ke Liu et al.   BMC CANCER

Prognostic Value of Loss of Heterozygosity at Chromosome 9p in Non–muscle-invasive Bladder Cancer

(2010) Guillaume Ploussard et al.   UROLOGY

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients

(2009) Z.-S. Zhao et al.   CLINICAL CANCER RESEARCH

Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer

(2009) G. Yu et al.   CLINICAL CANCER RESEARCH

Nature meets nurture: molecular genetics of gastric cancer

(2009) Anya N. Milne et al.   HUMAN GENETICS

Clinical Significance of Loss of Fhl1 Expression in Human Gastric Cancer

(2008) Katsuya Sakashita et al.   ANNALS OF SURGICAL ONCOLOGY

Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer

(2008) Guanzhen Yu et al.   CLINICAL & EXPERIMENTAL METASTASIS

Prognostic Role of Loss of Heterozygosity on Chromosome 18 in Patients With Low-Risk Nonmuscle-Invasive Bladder Cancer: Results from a Prospective Study

(2008) Tommaso Cai et al.   JOURNAL OF SURGICAL RESEARCH

Altered tissue repair in hevin-null mice: Inhibition of fibroblast migration by a matricellular SPARC homolog

(2008) Millicent M. Sullivan et al.   WOUND REPAIR AND REGENERATION